“Dupilumab with Concomitant Topical Corticosteroids in Atopic Dermatitis Patients who are Inadequately Controlled with or Medically Inadvisable for Cyclosporine A: a Phase 3 Clinical Trial (LIBERTY AD CAFE)”, J of Skin, vol. 1, no. 3.1, p. s37, Oct. 2017, doi: 10.25251/skin.1.supp.36.